2012中国民营医院·竞争力100强排行榜发布

2013-11-21 MedSci MedSci原创

    在武汉的“2013中国民营医院发展年会”举行期间,发布了由香港艾力彼医院管理研究中心和香港《医院观察》杂志联合主办的2012“中国民营医院·竞争力100强”排名总榜单,引发了与会嘉宾的强烈关注。    在国务院日印发《关于促进健康服务业发展的若干意见》为多元化办医吹响号角以及《民营医院发展蓝皮书》推出后,“中国民营医院·竞争力100强排名”的推出,无

    在武汉的“2013中国民营医院发展年会”举行期间,发布了由香港艾力彼医院管理研究中心和香港《医院观察》杂志联合主办的2012“中国民营医院·竞争力100强”排名总榜单,引发了与会嘉宾的强烈关注。
    在国务院日印发《关于促进健康服务业发展的若干意见》为多元化办医吹响号角以及《民营医院发展蓝皮书》推出后,“中国民营医院·竞争力100强排名”的推出,无疑为民营医院的发展树立起了标杆,为民营医院的健康发展提供了强有力的参考。
    在医改新政推动下,民营医院的发展呈迅猛势头。据卫计委统计数字,截至2013年7月底,我国民营医院数量已达10594家,占全国医院总数的44%。但讽刺的是,如此规模的一个群体,既往遭受医疗政策的冷遇,一直生存困难,这无疑是助长公立医院垄断的主因。
    有鉴于民营医院的发展对中国医疗体系所具有的重要意义,香港艾力彼医院管理研究中心和香港《医院观察》杂志继成功发布三届中国医院·竞争力排名后,秉承“数据说话”的精髓及客观、科学和公正的原则,对中国民营医院的生存与发展进行系统研究,通过严格的筛选、核实和评比,正式推出第一届“民营医院·竞争力100强”排行榜,为医改提供借鉴,为业界提供标杆和参照体系。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1752452, encodeId=b5541e5245263, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Fri Feb 14 03:56:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764654, encodeId=3ed21e646544a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Thu Apr 17 16:56:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425490, encodeId=9ae7142549060, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495426, encodeId=df301495426ec, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1752452, encodeId=b5541e5245263, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Fri Feb 14 03:56:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764654, encodeId=3ed21e646544a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Thu Apr 17 16:56:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425490, encodeId=9ae7142549060, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495426, encodeId=df301495426ec, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1752452, encodeId=b5541e5245263, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Fri Feb 14 03:56:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764654, encodeId=3ed21e646544a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Thu Apr 17 16:56:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425490, encodeId=9ae7142549060, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495426, encodeId=df301495426ec, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1752452, encodeId=b5541e5245263, content=<a href='/topic/show?id=1bbd63e40fd' target=_blank style='color:#2F92EE;'>#民营#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63740, encryptionId=1bbd63e40fd, topicName=民营)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0c36549805, createdName=chaojitidian, createdTime=Fri Feb 14 03:56:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764654, encodeId=3ed21e646544a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Thu Apr 17 16:56:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425490, encodeId=9ae7142549060, content=<a href='/topic/show?id=b04463e47bb' target=_blank style='color:#2F92EE;'>#民营医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63747, encryptionId=b04463e47bb, topicName=民营医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5213977322, createdName=LSJ112, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495426, encodeId=df301495426ec, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Nov 23 13:56:00 CST 2013, time=2013-11-23, status=1, ipAttribution=)]
    2013-11-23 仁医06